Results 151 to 160 of about 33,517,941 (337)

Information Systems [PDF]

open access: yesYearbook of Medical Informatics, 1995
openaire   +2 more sources

EGFR‐STAT3 activation provides a therapeutic rationale for targeting aggressive ETV1‐positive prostate cancer

open access: yesMolecular Oncology, EarlyView.
Cotargeting EGFR and STAT3 with Erlotinib and TTI‐101 impairs both 2D and 3D growth of ETV1‐overexpressing prostate cancer cells by disrupting a self‐sustaining ETV1–EGFR positive feedback loop that promotes EGFR and STAT3 expression and phosphorylation (activation).
Elsa Gomes Paiva   +5 more
wiley   +1 more source

AVariablebitrateVideoCodingSchemeBasedonMorphologicalOperationsforATMNetworks

open access: yesTongxin xuebao, 1998
Chen Huifang Dai Wenqi Qiu Peiliang (Institute of Information and Intelligent System   +2 more
doaj   +2 more sources

A High-Speed Weather Information Distribution System [PDF]

open access: hybrid, 1963
P. I. Hershberg
openalex   +1 more source

Information Systems [PDF]

open access: yesYearbook of Medical Informatics, 1997
openaire   +2 more sources

Cytomegalovirus infection is common in prostate cancer and antiviral therapies inhibit progression in disease models

open access: yesMolecular Oncology, EarlyView.
Human cytomegalovirus infection is common in normal prostate epithelium, prostate tumor tissue, and prostate cancer cell lines. CMV promotes cell survival, proliferation, and androgen receptor signaling. Anti‐CMV pharmaceutical compounds in clinical use inhibited cell expansion in prostate cancer models in vitro and in vivo, motivating investigation ...
Johanna Classon   +13 more
wiley   +1 more source

MANAGEMENT AND INFORMATION SYSTEMS*) [PDF]

open access: yesMaandblad Voor Accountancy en Bedrijfseconomie, 1972
openaire   +3 more sources

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

open access: yesMolecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy